Tolerability of levetiracetam in elderly patients with CNS disorders

Author： Cramer J.A.   Leppik I.E.   Rue K.D.   Edrich P.   Kramer G.  

Publisher： Elsevier

ISSN： 0920-1211

Source： Epilepsy Research, Vol.56, Iss.2, 2003-10, pp. : 135-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Tolerability of Olanzapine in Elderly Patients with Psychotic Disorders: A Prospective Study

By Madhusoodanan S.  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 12, Iss. 1, 2000-03 ,pp. : 11-18

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and tolerability of 1000-4000 mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy

By Grant R.   Shorvon S.D.  

Epilepsy Research, Vol. 42, Iss. 2, 2000-12 ,pp. : 89-95

Elsevier

Access to resources Recommend Favorite

Use of Olanzapine for Elderly Patients with Psychotic Disorders: A Review

By Madhusoodanan S.  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 13, Iss. 4, 2001-12 ,pp. : 201-213

Springer Publishing Company

Access to resources Recommend Favorite

Deciphering Developmental CNS Disorders

By  

NeuroMolecular Medicine, Vol. 8, Iss. 4, 2006-12 ,pp. : 433-434

Humana Press, Inc

Access to resources Recommend Favorite

Subthreshold depressive and anxiety disorders in the elderly

By Heun R.   Papassotiropoulos A.   Ptok U.  

European Psychiatry, Vol. 15, Iss. 3, 2000-05 ,pp. : 173-182

Elsevier

Access to resources Recommend Favorite